Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex |
Park, Byoung Kwon
(Center for Medical Science Research, College of Medicine, Hallym University)
Maharjan, Sony (Center for Medical Science Research, College of Medicine, Hallym University) Lee, Su In (Center for Medical Science Research, College of Medicine, Hallym University) Kim, Jinsoo (Department of Microbiology, College of Medicine, Hallym University) Bae, Joon-Yong (Department of Microbiology, College of Medicine, and the Institute for Viral Diseases, Korea University) Park, Man-Seong (Department of Microbiology, College of Medicine, and the Institute for Viral Diseases, Korea University) Kwon, Hyung-Joo (Center for Medical Science Research, College of Medicine, Hallym University) |
1 | Park BK, Lee SI, Bae JY et al (2018) Production of a Monoclonal Antibody targeting the M protein of MERSCoV for detection of MERS-CoV using a synthetic peptide epitope formulated with a CpG-DNA-liposome complex. Int J Pept Res Ther https://doi.org/10.1007/s10989-018-9731-8 |
2 | Salazar G, Zhang N, Fu TM and An Z (2017) Antibody therapies for the prevention and treatment of viral infections. NPJ Vaccines 2, 19 DOI |
3 | Park BK, Park JY, Kim TH et al (2018) Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer. Int J Oncol 53, 275-285 |
4 | Wu G, Maharjan S, Kim D et al (2018) A Novel monoclonal antibody targets mucin1 and attenuates growth in pancreatic cancer model. Int J Mol Sci 19, 2004 DOI |
5 | Park BK, Gautam A, Maharjan S et al (2017) Production of anti-c-Myc monoclonal antibody inhibiting DNA binding of c-Myc and max dimer by epitope peptide-CpGDNA-liposome complex without carriers. Int J Pept Res Ther https://doi.org/10.1007/s10989-017-9649-6 |
6 | Wu G, Kim D, Kim JN et al (2018) A Mucin1 C-terminal subunit-directed monoclonal antibody targets overexpressed Mucin1 in breast cancer. Theranostics 8, 78-91 DOI |
7 | Kim D, Kwon S, Rhee JW et al (2011) Production of antibodies with peptide-CpG-DNA-liposome complex without carriers. BMC Immunol 12, 29 DOI |
8 | Maharjan S, Park BK, Lee SI et al (2018) Gomisin G inhibits the growth of triple-negative breast cancer cells by suppressing AKT phosphorylation and decreasing cyclin D1. Biomol Ther (Seoul) 26, 322-327 DOI |
9 | Maharjan S, Park BK, Lee SI et al (2018) Gomisin G suppresses the growth of colon cancer cells by attenuation of AKT phosphorylation and arrest of cell cycle progression. Biomol Ther (Seoul) https://doi.org/10.4062/biomolther.2018.054 |
10 | Jo HS, Eum WS, Park EY et al (2017) Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease. BMB Rep 50, 460-465 DOI |
11 | Lee EW, Oh W, Song HP and Kim WK (2017) Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53. BMB Rep 50, 373-378 DOI |
12 | Yokoyama WM, Christensen M, Santos GD and Miller D (2006) Production of monoclonal antibodies. Curr Protoc Immunol 102, Unit 2.5 |
13 | Durai P, Batool M, Shah M and Choi S (2015) Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control. Exp Mol Med 47, e181 DOI |
14 | Zumla A, Chan JF, Azhar EI et al (2016) Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov 15, 327-347 DOI |
15 | Du L, Yang Y, Zhou Y et al (2017) MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets 21, 131-143 DOI |
16 | Mackay IM and Arden KE (2015) MERS coronavirus: diagnostics, epidemiology and transmission. Virol J 12, 222 DOI |
17 | Zaki AM, van Boheemen S, Bestebroer TM et al (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367, 1814-1820 DOI |
18 | Omrani AS, Al-Tawfiq JA and Memish ZA (2015) Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction. Pathog Glob Health 109, 354-362 DOI |
19 | World Health Organization, Middle East respiratory syndrome coronavirus (MERS-CoV), 2018. (http://www.who.int/emergencies/mers-cov/en/) |
20 | Ki M (2015) 2015 MERS outbreak in Korea: hospital-tohospital transmission. Epidemiol Health 37, e2015033 DOI |
21 | Lambour J, Naranjo-Gomez M, Piechaczyk M and Pelegrin M (2016) Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play. Emerg Microbes Infect 5, e92 DOI |
22 | Scott AM, Allison JP and Wolchok JD (2012) Monoclonal antibodies in cancer therapy. Cancer Immun 12, 14 |
23 | Wang Q, Wong G, Lu G et al (2016) MERS-CoV spike protein: Targets for vaccines and therapeutics. Antiviral Res 133, 165-177 DOI |
24 | Kim D, Kwon HJ and Lee Y (2011) Activation of Toll-like receptor 9 and production of epitope specific antibody by liposome-encapsulated CpG-DNA. BMB Rep 44, 607-612 DOI |
25 | Gao J, Lu G, Qi J et al (2013) Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol 87, 13134-13140 DOI |
26 | Wang N, Shi X, Jiang L et al (2013) Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 23, 986-993 DOI |
27 | Raj VS, Mou H, Smits SL et al (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251-254 DOI |
28 | Park BK, Choi SH, Kim YE et al (2015) Monoclonal antibodies against the human respiratory syncytial virus obtained by immunization with epitope peptides and CpG-DNA-liposome complex. Monoclon Antib Immunodiagn Immunother 34, 101-109 DOI |
29 | Rhee JW, Kim D, Park et al (2012) Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice. PLoS One 7, e48750 DOI |
![]() |